These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 18838583

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z, Cao B, Liu YM, Gu L, Wang C.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138
    [Abstract] [Full Text] [Related]

  • 24. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
    Feng NN, Wang Q, Song YL, He LX, Zhou CM, Xie HM, Li HY.
    Zhonghua Nei Ke Za Zhi; 2013 Apr 05; 52(4):318-22. PubMed ID: 23925360
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus.
    Deresinski S.
    J Infect Dis; 2009 Mar 01; 199(5):605-9. PubMed ID: 19199551
    [No Abstract] [Full Text] [Related]

  • 28. Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it.
    Hawkey PM.
    Clin Microbiol Infect; 2009 Dec 01; 15 Suppl 7():2-9. PubMed ID: 19951328
    [Abstract] [Full Text] [Related]

  • 29. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
    Rebiahi SA, Abdelouahid DE, Rahmoun M, Abdelali S, Azzaoui H.
    Med Mal Infect; 2011 Dec 01; 41(12):646-51. PubMed ID: 22033230
    [Abstract] [Full Text] [Related]

  • 30. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
    Fridkin SK.
    Clin Infect Dis; 2001 Jan 01; 32(1):108-15. PubMed ID: 11118389
    [Abstract] [Full Text] [Related]

  • 31. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 01; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 32. [Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: a Belgian hospital].
    Piérard D, Vandenbussche H, Verschraegen I, Lauwers S.
    Pathol Biol (Paris); 2004 Oct 01; 52(8):486-8. PubMed ID: 15465269
    [Abstract] [Full Text] [Related]

  • 33. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR, Rhomberg PR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2008 Apr 01; 60(4):399-403. PubMed ID: 18178361
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Sanprasitthiprasong Hospital.
    Panomket P, Thirat S, Wanram S, Sranujit RP.
    J Med Assoc Thai; 2014 Apr 01; 97 Suppl 4():S7-11. PubMed ID: 24851558
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparing antimicrobial susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin using MicroScan (Pos Combo 3.1J) and conventional methods.
    Nakashima H, Kameko M, Takahashi H, Saito H.
    Int J Antimicrob Agents; 2010 Sep 01; 36(3):291-3. PubMed ID: 20594808
    [No Abstract] [Full Text] [Related]

  • 39. Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital.
    Bassetti M, Mesini A, Molinari MP, Viscoli C.
    Int J Antimicrob Agents; 2011 Nov 01; 38(5):453-4. PubMed ID: 21872450
    [No Abstract] [Full Text] [Related]

  • 40. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE, Poppens PT.
    J Antimicrob Chemother; 2009 Mar 01; 63(3):485-8. PubMed ID: 19109338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.